Welcome to our dedicated page for Claritev news (Ticker: CTEV), a resource for investors and traders seeking the latest updates and insights on Claritev stock.
Claritev Corporation (NYSE: CTEV) is a healthcare technology, data and insights company that regularly issues news on its role in improving healthcare affordability, transparency and quality. As a health information services and healthcare technology provider, Claritev uses AI-driven analytics and decades of claims experience to support payors, employers, providers, patients and third parties across the healthcare ecosystem. Its news flow reflects both operating performance and strategic initiatives tied to this mission.
On this page, readers can follow Claritev news related to quarterly financial results, investor presentations and participation in major healthcare and finance conferences. The company frequently announces earnings for periods such as its third quarter, along with updates on revenues, net income or loss, Adjusted EBITDA and other financial metrics. These releases often include commentary on business momentum, guidance updates and the scale of claim charges processed and potential medical cost savings identified.
Claritev also publishes news about client relationships and contracts, including renewals with its largest clients and information about multi-year agreements that cover a significant share of its revenues. In addition, the company highlights strategic partnerships and international initiatives, such as agreements to deliver AI-powered revenue cycle management platforms in the Middle East and North Africa and investments in healthcare payment-acceleration providers that connect its U.S. presence with activity in the MENA region.
Other Claritev announcements include brand and sponsorship activities, such as golf sponsorships with professional players that the company positions as ambassadors for its values. For investors, analysts and observers of the healthcare technology sector, this news page provides a centralized view of Claritev’s public disclosures, from financial updates and capital markets transactions to technology collaborations and market expansion efforts.
Claritev (NYSE: CTEV) will release its Q1 fiscal 2026 financial results before market open on Thursday, May 7, 2026 and will host a conference call at 8:00 AM ET. A live webcast, supplemental slide deck, and replay will be available in the Investor Relations section of the company's website.
Participants may join the webcast ten minutes early or dial in at 646-968-2525 with Conference ID 2181839 for an operator-assisted call.
Claritev (NYSE: CTEV) launched Claritev Cares, a nonprofit foundation expanding its longstanding rural health grant program and charitable initiatives. Applications for the Claritev Cares Rural Health Grant are open through June 1, 2026. Since 1995, Claritev has contributed over $700,000 via 100+ rural grants.
The foundation also supports food-as-medicine causes, veteran health, and global relief, including a $10,000 donation to World Central Kitchen, and emphasizes associate-driven priorities and measurable community impact.
Claritev (NYSE: CTEV) said members of its management team will meet investors at three events in March 2026, including virtual and in-person meetings and a webcast.
Events listed: Mizuho Virtual Healthcare Technology Conference (March 5, 2026), a Nephron Research Q&A webcast (March 6, 2026 at 11 a.m. ET), and Barclays 28th Annual Global Healthcare Conference (listed March 11, 2025 in Miami Beach) with one-on-one meetings; webcast access is via the company investor site.
Claritev (NYSE: CTEV) will host its 2026 Investor Day on Monday, March 16, 2026 at the New York Stock Exchange. The event starts at 1:00 p.m. ET and includes management presentations on growth strategy, vertical markets, product roadmap, and financial outlook.
A live webcast is available via registration at https://www.claritev.com/investor-day-2026/, and an archive replay will remain accessible for one year after the event.
Claritev (NYSE: CTEV) reported Q4 2025 revenue of $246.6 million, Q4 adjusted EBITDA of $151.3 million (61.4% margin), and Q4 net loss of $80.6 million. Full-year 2025 revenue was $965.4 million, adjusted EBITDA $602.6 million, and net loss $284.3 million.
The company initiated 2026 guidance: $980M–$1.0B revenue, adjusted EBITDA $605M–$615M, capex $160M–$170M, and free cash flow $0M–$10M. The board approved a $75M, five-year share repurchase program.
Claritev (NYSE: CTEV) will release fourth quarter and fiscal year 2025 results after market close on Monday, February 23, 2026 and host an earnings conference call the same day at 4:30 PM ET. Participants may pre-register to receive a unique PIN and calendar invite.
A live webcast, press release, and supplemental slide deck will be available in the Investor Relations section at investors.claritev.com/events-and-presentations. A replay will be archived on the same page after the call.
Claritev (NYSE: CTEV) announced a strategic relationship with Kinetiq Health to integrate Kinetiq’s claims surveillance, diagnostic second‑opinion services, and cost‑intervention expertise into Claritev’s BenInsights analytics platform.
The combined offering provides monthly medical and pharmacy claims surveillance, risk stratification, and access to a Second Opinion Program to identify emerging high‑cost claims early, support diagnostic certainty, and reduce avoidable spend. From 2020–2024 Kinetiq clients’ average claims trend was 2.48% versus an industry average of 8%.
Claritev (NYSE: CTEV) will present at the 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026 at 7:30 a.m. PT. Management's presentation will be accessible by live webcast and an audio archive via the company's investor relations site: investors.claritev.com/events-and-presentations. For one-on-one meetings, interested parties should contact a representative at the host firm.
Claritev (NYSE: CTEV) announced that its management team will participate in three investor conferences in early December 2025: BofA Securities Leveraged Finance Conference on Dec 2, 2025 at The Boca Raton (presentation ~7:30 AM ET), Citi 2025 Global Healthcare Conference on Dec 3, 2025 at Intercontinental Miami, and Piper Sandler 37th Annual Healthcare Conference on Dec 4, 2025 at Lotte New York Palace (fireside chat 8:00 AM ET).
Where available, live webcasts and audio archives will be posted at investors.claritev.com/events-and-presentations. For one-on-one meetings, attendees should contact representatives at the host firms.
Claritev (NYSE: CTEV) announced an underwritten public offering by selling stockholders of 1,500,000 shares of Class A common stock at $51.50 per share, with a 30-day option for up to an additional 225,000 shares. Claritev will not sell shares and will receive no proceeds from the Offering. The Offering is expected to close by November 14, 2025, subject to customary closing conditions. Joint-lead bookrunning managers are Barclays, Guggenheim Securities and Wells Fargo Securities; Citigroup and Piper Sandler are additional bookrunners. A prospectus supplement will be filed with the SEC; investors should review the prospectus for full details.